Metformin Antihyperglycemic Drug

Cat.No.S5958

Metformin (1,1-Dimethylbiguanide), a widely used drug for treatment of type 2 diabetes, activates AMP-activated protein kinase (AMPK) in hepatocytes. Metformin promotes mitophagy in mononuclear cells. Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153.
Metformin AMPK activator Chemical Structure

Chemical Structure

Molecular Weight: 129.16

Quality Control

Chemical Information, Storage & Stability

Molecular Weight 129.16 Formula

C4H11N5

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 657-24-9 -- Storage of Stock Solutions

Solubility

In vitro
Batch:

Water : 130 mg/mL

DMSO : 26 mg/mL ( (201.3 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 26 mg/mL

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
AMPK [1]
JNK [3]
p38 MAPK [3]
In vitro

Metformin upregulates BAX activation with facilitation of BIM, BAD and PUMA, downregulates Bcl-2 and Bcl-xl, also induces cytochrome c release from mitochondria into the cytoplasm, directly triggering caspase-9-mediated mitochondrial apoptosis.[4]

In vivo

Metformin shows therapeutic effect of this compound in mouse model of liver fibrosis associated with nonalcoholic steatohepatitis (NASH) in which hepatic function, NASH lesions and fibrosis are improved.[4]

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05910554 Not yet recruiting
Sarcoidosis Pulmonary
University of Maryland Baltimore
May 1 2024 Phase 2
NCT06120881 Recruiting
Type 2 Diabetes
University of California San Francisco|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
April 1 2024 Early Phase 1
NCT06147050 Not yet recruiting
Long COVID
Purpose Life Sciences
April 2024 Phase 3
NCT06296836 Not yet recruiting
Diabetes Mellitus Type 2
University of Illinois at Chicago|Emily Hanners|Dulal Bhaumik|Avisek Datta|Peggy Choye|Hailey Soni|Annesti Elmasri|Julie Jun|Colin Goodman
April 1 2024 Phase 4

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Signaling Pathway Map